In 2022, MEDIPAL continued its policy of expanding the geography of its presence and opened 2 representative offices in Uzbekistan and the Republic of Belarus.
The Representative Offices aim at promoting in-demand medicines in the OTC segment (over-the-counter medicines), developing and strengthening mutually beneficial cooperation under a partnership agreement with Sanofi.
Since 2014, MEDIPAL has been actively working to develop the export of products of the largest pharmaceutical manufacturers and to provide access for patients to high-quality medicines at the highest level. Sanofi is one of the world leaders in healthcare, developing and implementing therapeutic solutions to meet the various needs of patients.
The company’s vision rests on the following principles of growth: modern solutions to treat diabetes mellitus, human vaccines, innovative medicines, over-the-counter drugs, health products, emerging markets, and veterinary drug products.
We use cookies to analyze events on our website, which allows us to improve the site's performance. If you do not want your data to be processed, please disable cookies in your browser settings. By continuing to use our site, you accept its terms of use and give your consent to the processing of cookies. For more detailed information on the use of cookies and how to opt out, please refer to our Cookie Policy.